Bio-Connect

C1GALT1C1 antibody [N3C3]

GTX115877
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman, Rat
TargetC1GALT1C1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    C1GALT1C1 antibody [N3C3]
  • Delivery Days Customer
    9
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.98 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID29071
  • Target name
    C1GALT1C1
  • Target description
    C1GALT1 specific chaperone 1
  • Target synonyms
    AHUS8, C1GALT2, C38H2-L1, COSMC, HSPC067, MST143, TNPS, C1GALT1-specific chaperone 1, C38H2-like protein 1, beta 1,3-galactosyltransferase 2, core 1 beta1,3-galactosyltransferase 2, core 1 beta3-Gal-T-specific molecular chaperone, core 1 beta3-Gal-T2, core 1 beta3-galactosyltransferase-specific molecular chaperone
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ96EU7
  • Protein Name
    C1GALT1-specific chaperone 1
  • Scientific Description
    This gene encodes a type II transmembrane protein that is similar to the core 1 beta1,3-galactosyltransferase 1, which catalyzes the synthesis of the core-1 structure, also known as Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks the galactosyltransferase activity itself, but instead acts as a molecular chaperone required for the folding, stability and full activity of the core 1 beta1,3-galactosyltransferase 1. Mutations in this gene have been associated with Tn syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq]
  • Reactivity
    Human, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Nagai-Okatani C, Minamino N. Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure. PLoS One. 2016,11(6):e0150210. doi: 10.1371/journal.pone.0150210
    Read this paper